1
![Biotie Therapies]()
![Biotie Therapies]()
![Biotie Therapies]()
Biotie Therapies
Leadership team
Markku Jalkanen (Founder)
Products/ Services
Biotechnology, Health Care, Medical, Pharmaceutical
Number of Employees
0 - 50
Headquarters
Finans, Nigde, Turkey
Established
1992
Company Registration
SEC CIK number: 0001579695
Traded as
NASDAQ:BITI
Overview
Location
Summary
Biotie Therapies is a biopharmaceutical company established with a vision to develop innovative therapies for neurodegenerative and psychiatric disorders, substance abuse, and other indications.
History
Biotie Therapies was founded in 1999, as a response to the increasing need for innovative treatments for neurological and related diseases. Biotie quickly made a name for itself as a leading biopharmaceutical company dedicated to the development of novel therapeutic solutions and treatments for patients suffering from diseases of the nervous system.
Mission
Our mission is to improve the quality of life for patients with neurological diseases and disorders by developing and delivering innovative, safe, and effective therapies.
Vision
Our vision is to create an environment where we can comprehensively tackle neurological disorders and build an ecosystem that allows for the complete development of patients suffering from these illnesses.
Key Team
Markku Jalkanen (Founder)
Recognition and Awards
Biotie Therapies has won multiple awards, including the Top 100 Pharmaceutical Companies of 2015 from UBS, the Innovation Award from Science magazine in 2014, and the European Health Care Innovation Award from 2013.
References
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.
Leadership team
Markku Jalkanen (Founder)
Products/ Services
Biotechnology, Health Care, Medical, Pharmaceutical
Number of Employees
0 - 50
Headquarters
Finans, Nigde, Turkey
Established
1992
Company Registration
SEC CIK number: 0001579695
Traded as
NASDAQ:BITI